Industry Sponsorship and Authorship of Clinical Trials Over 20 Years

  title={Industry Sponsorship and Authorship of Clinical Trials Over 20 Years},
  author={S. S. Buchkowsky and P. Jewesson},
  journal={Annals of Pharmacotherapy},
  pages={579 - 585}
  • S. S. Buchkowsky, P. Jewesson
  • Published 2004
  • Medicine
  • Annals of Pharmacotherapy
  • BACKGROUND The pharmaceutical industry has become a major source of funding for biomedical research. Our general observation is that pharmaceutical industry employees are appearing with increasing frequency as coauthors of clinical trial publications. OBJECTIVE To characterize clinical trial funding, reporting, and sources; investigate author—industry affiliation; and describe clinical outcome trends over time. METHODS We reviewed 500 randomly selected clinical trials published in 5 influential… CONTINUE READING
    105 Citations

    Figures, Tables, and Topics from this paper

    Industry sponsorship and research outcome.
    • 365
    • PDF
    Controversies surrounding authorship of manuscripts by industry employees: academic and industry perspectives.
    • Nathaniel R Smilowitz, J. Ferguson, G. Weisz
    • Medicine
    • EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
    • 2018
    • PDF
    Relationships between authorship contributions and authors' industry financial ties among oncology clinical trials.
    • 34
    Disclosure of conflicts of interest by authors of clinical trials and editorials in oncology.
    • 57
    Industry-sponsored research.
    • 37


    Source of funding and outcome of clinical trials
    • R. Davidson
    • Medicine
    • Journal of general internal medicine
    • 1986
    • 259
    The uncertainty principle and industry-sponsored research
    • 452
    • PDF
    Publication bias and clinical trials.
    • 602
    Bias in reporting clinical trials.
    • A. Bardy
    • Medicine
    • British journal of clinical pharmacology
    • 1998
    • 60
    Uneasy alliance--clinical investigators and the pharmaceutical industry.
    • 736
    • PDF